Covidien Invests $45 Million into China Technology Center
publication date: Aug 2, 2012
Covidien, a global company that makes medical devices and other healthcare products, officially opened its China Technology Center R&D facility in Shanghai’s Caohejing Hi-Tech Park. Over a three-year period, Covidien will invest $45 million into the CTC, which will eventually employ over 300 people. The CTC contains 17 laboratories in its 100,000 square feet of floor space, and its state-of-the-art simulation sites will actively involve healthcare professionals in the design and development of medical devices. More details....
Stock Symbol: (NYSE: COV)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.